1,024 material Form 8-K filings that 799 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Abercrombie & Fitch reported second-quarter fiscal 2025 net sales of $1.2 billion, up 7% from a year earlier, and raised its full-year net sales growth outlook to 5% to 7%. GAAP diluted EPS rose to $2.91 from $2.50, helped by a $39 million pre-tax litigation settlement benefit; excluding that item, adjusted EPS was $2.32, down from $2.50 a year earlier. The company also set its full-year EPS outlook at $10.00 to $10.50 and estimates about $90 million of net tariff expense.
Net sales of $1.2 billion, up 7%: Hollister brands up 19%, Abercrombie brands down 5%.
GAAP EPS $2.91 vs. $2.50 a year earlier; adjusted EPS $2.32 vs. $2.50, excluding a $0.59 per share litigation settlement benefit.
Full-year net sales growth outlook raised to 5% to 7% from 3% to 6%; full-year EPS outlook $10.00 to $10.50.
Third-quarter EPS outlook of $2.05 to $2.25; the company repurchased $50 million of shares in the quarter.
Bath & Body Works reported second-quarter 2025 net sales up 1.5% to $1.549 billion, but diluted earnings per share fell to $0.30 from $0.68 a year earlier, and adjusted EPS was flat at $0.37. The company raised the low end of its full-year adjusted EPS guidance to $3.35 from $3.25 and expects a larger share repurchase, but its full-year GAAP EPS guidance of $3.28 to $3.53 is below 2024's $3.61.
Q2 net sales were $1,549 million, up from $1,526 million, while net income fell to $64 million from $152 million.
Adjusted EPS was $0.37, flat with last year; adjusted operating income was $172 million versus $183 million.
Full-year 2025 adjusted EPS guidance is $3.35 to $3.60, with the low end raised from $3.25; GAAP EPS guidance is $3.28 to $3.53 versus $3.61 in fiscal 2024.
Share repurchase expectation for 2025 rose to $400 million from $300 million; third-quarter EPS is expected at $0.37 to $0.45 versus $0.49 a year earlier.
Victoria's Secret & Co. reported second quarter 2025 net sales of $1.459 billion, up 3% and above its guidance range of $1.380 billion to $1.410 billion. Profit was lower: GAAP net income attributable to the company was $16 million, or $0.20 per diluted share, versus $32 million, or $0.40, a year earlier, and adjusted EPS was $0.33 versus $0.40. The company raised full-year net sales guidance but expects a third-quarter adjusted operating loss.
Q2 net sales $1.459 billion, up 3% from $1.417 billion; total comparable sales up 4%.
Q2 operating income $41 million vs. $62 million a year earlier; adjusted operating income $55 million vs. guidance of $15 million to $35 million.
Full-year net sales guidance raised to $6.330 billion to $6.410 billion from $6.2 billion to $6.3 billion; adjusted operating income outlook reiterated at $270 million to $320 million.
Third-quarter adjusted operating loss expected at $35 million to $55 million; adjusted net loss per share $0.55 to $0.75.
BILL reported fourth-quarter and fiscal 2025 results for the period ended June 30, 2025, with total revenue up 12% in the quarter and 13% for the full year, and its board authorized up to $300 million in share repurchases. The company posted a fourth-quarter GAAP net loss of $7.1 million, compared with net income of $7.6 million a year earlier, while full-year GAAP net income was $23.8 million, compared with a net loss of $28.9 million. Shareholders should note that the repurchase program does not obligate the company to buy any specific amount of stock, and fiscal 2026 total revenue guidance is $1,589.5 million to $1,629.5 million.
Q4 fiscal 2025 total revenue was $383.3 million, up 12% year-over-year; core revenue was $345.9 million, up 15%.
Q4 GAAP net loss was $7.1 million, or $0.07 per share, versus net income of $7.6 million in Q4 fiscal 2024; non-GAAP operating income was $56.4 million, down 6%.
Fiscal 2025 total revenue was $1,462.6 million, up 13%, and GAAP net income was $23.8 million versus a net loss of $28.9 million in fiscal 2024.
The $300 million share repurchase program has no set end date; the company expects to fund it with existing cash. Fiscal 2026 non-GAAP net income per diluted share guidance is $2.00 to $2.20.
REX American Resources reported fiscal second-quarter 2025 net sales and revenue of $158.6 million, up from $148.2 million a year earlier, but net income attributable to REX shareholders fell to $7.1 million from $12.4 million and diluted earnings per share fell to $0.43 from $0.70. The board also declared a 2-for-1 stock split, payable September 15, 2025 to holders of record on September 8, 2025, which would roughly double the outstanding share count to 33,057,574 shares.
Net sales and revenue rose to $158.6 million from $148.2 million, which the company attributes mainly to higher volumes despite lower ethanol and distillers grain prices.
Gross profit fell to $14.3 million from $19.8 million, and diluted EPS fell to $0.43 from $0.70.
The 2-for-1 stock split is a 100% stock dividend payable September 15, 2025 to shareholders of record on September 8, 2025.
Cash, cash equivalents and short-term investments totaled $310.5 million at July 31, 2025, with no bank debt.
J.M. Smucker reported a fiscal 2026 first-quarter net loss of $0.41 per diluted share, compared with net income of $1.74 per share a year earlier, while net sales fell 1% to $2.1 billion. Adjusted earnings per share fell 22% to $1.90, and operating cash flow was negative $10.6 million. The company raised its full-year net sales growth outlook to 3.0% to 5.0% and its free cash flow outlook to $975.0 million, but kept its adjusted earnings per share guidance at $8.50 to $9.50.
Net sales were $2.1 billion, down $11.8 million or 1%; excluding divestitures and currency, net sales rose 2%.
Net loss per diluted share was $0.41, versus net income of $1.74 per share a year earlier; GAAP operating income fell 87% to $45.6 million.
Adjusted earnings per share were $1.90, down 22% from $2.44.
FY2026 net sales growth outlook raised to 3.0% to 5.0% from 2.0% to 4.0%; adjusted earnings per share guidance unchanged at $8.50 to $9.50; free cash flow outlook raised to $975.0 million from $875.0 million.
Kohl's reported second-quarter fiscal 2025 net sales down 5.1% to $3.3 billion, with comparable sales down 4.2%. GAAP diluted EPS was $1.35, helped by a $129 million gain on a credit card interchange fee lawsuit settlement, while adjusted diluted EPS was $0.56 versus $0.59 a year earlier. The company raised its full-year 2025 outlook, and its board reduced the annual cash dividend to $0.50 per share to give the company more balance sheet flexibility.
Net sales fell 5.1% to $3.3 billion; gross margin rose 28 basis points to 39.9%
GAAP diluted EPS of $1.35 versus $0.59 a year earlier; adjusted diluted EPS of $0.56 versus $0.59
Full-year 2025 adjusted diluted EPS guidance of $0.50 to $0.80; net sales expected to decline 5% to 6%
Quarterly dividend of $0.125 per share payable September 24, 2025; presentation says annual dividend reduced to $0.50 per share
PVH reported second-quarter 2025 revenue of $2.167 billion, up 4% from a year earlier, and non-GAAP earnings per share of $2.52, which beat guidance of $1.85 to $2.00 but fell from $3.01 a year earlier. The company raised its full-year revenue outlook and reaffirmed its non-GAAP EPS range of $10.75 to $11.00, while gross margin declined to 57.7% from 60.1% amid tariffs and promotions.
Non-GAAP EPS was $2.52 versus $3.01 a year earlier and above prior guidance of $1.85 to $2.00; GAAP EPS was $4.63 versus $2.80.
Gross margin fell to 57.7% from 60.1%; non-GAAP EBIT was $178 million versus $189 million a year earlier.
Full-year revenue outlook was raised to increase slightly to up low single digits; non-GAAP EPS outlook of $10.75 to $11.00 was reaffirmed.
No share repurchase payments were made in the second quarter, and none are expected for the rest of 2025 after $561 million of purchases in the first quarter.
Ross Stores reported second-quarter fiscal 2025 diluted EPS of $1.56 on net income of $508 million, down from $1.59 a year earlier, while sales rose 5% to $5.5 billion. The company said tariff-related costs weighed on margins, and it set fiscal 2025 EPS guidance of $6.08 to $6.21, compared with $6.32 last year, which matters to shareholders because it signals lower earnings for the year.
Q2 diluted EPS $1.56 vs $1.59 a year earlier; net income $508 million vs $527 million
Q2 sales up 5% to $5.5 billion; comparable store sales up 2%; operating margin down 95 basis points to 11.5%
Fiscal 2025 EPS now planned at $6.08 to $6.21 vs $6.32 last year; includes about $0.22 to $0.25 per share from announced trade policies
Repurchased 1.9 million shares for $262 million in Q2; on track for $1.05 billion in buybacks in fiscal 2025
Coty reported fiscal 2025 net revenue of $5,892.9 million, down 4%, and a reported net loss of $381.1 million, compared with net income of $76.2 million a year earlier. The loss reflects a $212.8 million non-cash asset impairment and a $248.1 million equity swap mark-to-market hit. The company expects first-quarter fiscal 2026 LFL sales to decline 6% to 8% and adjusted EBITDA to fall in the mid-to-high teens percentage, with a return to growth in the second half.
FY25 reported net loss was $381.1 million, or $(0.44) per diluted share, versus net income of $76.2 million in FY24.
Q4 net revenue was $1,252.4 million, down 8%, and Q4 adjusted EBITDA was $126.7 million, down 23%.
Guidance: 1Q26 LFL sales decline of 6% to 8%; 1Q26 adjusted EBITDA decline in the mid-to-high teens percentage.
1H26 adjusted EPS expected at $0.33 to $0.36; free cash flow in 1H26 expected to exceed $350 million.
Flowers Foods reported second-quarter results for the 12 weeks ended July 12, 2025. Net sales rose 1.5% to $1.243 billion, helped by the Simple Mills acquisition, while net income fell 12.8% to $58.4 million and diluted EPS fell to $0.28 from $0.32. The company also lowered its fiscal 2025 guidance for net sales, adjusted EBITDA and adjusted diluted EPS, citing softer traditional loaf sales and a more competitive environment.
Net sales rose 1.5% to $1.243 billion; Simple Mills added 5.1 percentage points, while pricing/mix fell 1.2% and volume fell 2.4%.
Net income fell 12.8% to $58.4 million; adjusted diluted EPS fell to $0.30 from $0.36.
Fiscal 2025 adjusted EBITDA guidance is $512 million to $538 million, down from $534 million to $562 million.
Fiscal 2025 adjusted diluted EPS guidance is $1.00 to $1.10, down from $1.05 to $1.15.
Tapestry reported fiscal fourth-quarter net sales of $1.72 billion, up 8%, and a GAAP net loss of $517 million, driven largely by an $855 million impairment on the Kate Spade brand. Non-GAAP earnings per diluted share rose to $1.04 from $0.92, and the company initiated fiscal 2026 non-GAAP EPS guidance of $5.30 to $5.45 and raised its dividend 14%.
Q4 net sales were $1.72 billion, up 8% on both reported and constant currency bases; GAAP net loss was $517 million, or $2.49 per diluted share, versus GAAP net income of $159 million a year earlier.
Q4 non-GAAP EPS was $1.04 versus $0.92; the quarter included an $855 million impairment on Kate Spade indefinite-lived brand intangible and goodwill.
Fiscal 2026 outlook calls for revenue approaching $7.2 billion and non-GAAP EPS of $5.30 to $5.45, including a negative tariff and duty impact of over $0.60 per share.
Quarterly dividend raised 14% to $0.40 per share, an anticipated $1.60 annual rate; the company expects $800 million in share repurchases in fiscal 2026.
Amcor reported fiscal fourth-quarter 2025 net sales of $5,082 million, up 44% on a reported basis, after the April 30, 2025 Berry Global acquisition, but posted a GAAP net loss of $39 million that included acquisition-related costs. For fiscal 2026, the company guided to adjusted EPS of 80 to 83 cents, representing 12% to 17% constant currency growth, and free cash flow of $1.8 billion to $1.9 billion.
Q4 net sales $5,082 million, up 44% reported and 43% constant currency; GAAP net loss $39 million, or 1.9 cents per diluted share.
Fiscal 2025 adjusted EPS 71.2 cents, up 3% constant currency; GAAP net income $511 million; adjusted free cash flow $926 million.
Fiscal 2026 guidance: adjusted EPS of 80 to 83 cents and free cash flow of $1.8 billion to $1.9 billion, including about $260 million of pre-tax synergy benefits.
Identified a $20 billion core portfolio and about $2.5 billion of less-aligned businesses under review; quarterly dividend raised to 12.75 cents from 12.5 cents.
CAVA Group reported fiscal second-quarter 2025 results for the period ended July 13, 2025, with CAVA Revenue up 20.3% to $278.2 million on 16 net new restaurant openings and same restaurant sales growth of 2.1%. Net income fell to $18.4 million from $19.7 million a year earlier, while Adjusted EBITDA rose 22.6% to $42.1 million, and the company cut its full-year same restaurant sales growth outlook to 4.0% to 6.0% from 6.0% to 8.0%.
CAVA Revenue grew 20.3% to $278.2 million versus $231.4 million in the prior-year quarter; total revenue was $280.6 million.
Net income was $18.4 million, down from $19.7 million; diluted EPS was $0.16 versus $0.17 a year earlier.
Adjusted EBITDA rose to $42.1 million from $34.3 million; CAVA Restaurant-Level Profit Margin was 26.3% versus 26.5%.
Updated fiscal 2025 guidance: same restaurant sales growth cut to 4.0% to 6.0%; net new openings raised to 68 to 70; Adjusted EBITDA unchanged at $152.0 million to $159.0 million.
Madison Square Garden Sports Corp. (MSGS) reported fiscal 2025 revenues of $1.04 billion, up 1%, but operating income fell to $14.8 million and the company recorded a net loss of $22.4 million for the year. In the fourth quarter, revenue fell 10% to $204.0 million and the company posted an operating loss, mainly due to higher direct operating expenses, which matters to shareholders because profit fell sharply even as annual sales edged up.
Fiscal 2025 revenues were $1,039.2 million, up $12.1 million, or 1%, from the prior year
Fiscal 2025 operating income was $14.8 million, down $131.2 million; net loss was $22.4 million, or $0.93 per diluted share
Fourth-quarter revenues were $204.0 million, down $23.3 million, or 10%; operating loss was $22.6 million versus operating income of $52.3 million a year earlier
Fourth-quarter direct operating expenses rose $47.1 million, or 44%, including $42.8 million of higher net provisions for certain team personnel transactions
TDS reported second-quarter 2025 operating revenues of $1,186 million, down from $1,238 million a year earlier, while its net loss attributable to common shareholders narrowed to $5 million, or $(0.05) per share, from $14 million, or $(0.13) per share. The company also lowered the top end of its TDS Telecom 2025 Adjusted OIBDA and Adjusted EBITDA estimates, which matters to shareholders because the revenue decline and narrower guidance range point to a softer telecom outlook.
Q2 2025 operating revenues were $1,186 million versus $1,238 million in Q2 2024.
Net loss attributable to TDS common shareholders was $(5) million, or $(0.05) per diluted share, versus $(14) million, or $(0.13), a year earlier.
TDS Telecom 2025 Adjusted OIBDA estimate narrowed to $310-$340 million from $310-$350 million; Adjusted EBITDA narrowed to $320-$350 million from $320-$360 million.
Array completed the sale of its wireless operations and select spectrum assets to T-Mobile on August 1, 2025, for total consideration of $4.3 billion.
AAM (NYSE: AXL) reported second-quarter 2025 sales of $1.54 billion, down from $1.63 billion a year earlier, while net income rose to $39.3 million from $18.2 million. The filing says the net income increase reflects a $46.3 million gain on its Business Combination Derivative, while Adjusted EBITDA fell to $202.2 million from $208.4 million, and the company raised the low end of several full-year 2025 targets.
Sales were $1.54 billion versus $1.63 billion a year earlier, which the company attributed to lower volume and mix.
Diluted EPS was $0.32 versus $0.15; Adjusted EPS was $0.21 versus $0.19. Adjusted EBITDA margin was 13.2% versus 12.8%.
Full-year 2025 targets: Adjusted EBITDA $695 million to $745 million (previously $665 million to $745 million); sales $5.75 billion to $5.95 billion (previously $5.65 billion to $5.95 billion).
CEO David C. Dauch said shareholders of both companies approved the combination with Dowlais.
Alpha Metallurgical Resources reported a second-quarter 2025 net loss of $5.0 million, or $0.38 per diluted share, narrowing from a $33.9 million loss in the first quarter but down from a $58.9 million profit a year earlier. The company lowered its 2025 cost of coal sales guidance to $101 to $107 per ton, cut its SG&A guidance, and raised its idle operations expense guidance. It also plans to restart its share repurchase program on an opportunistic basis, having refrained from buybacks for about five quarters.
Q2 2025 net loss of $5.0 million ($0.38 per diluted share) versus a $33.9 million loss in Q1 2025 and net income of $58.9 million in Q2 2024
Adjusted EBITDA of $46.1 million, up from $5.7 million in Q1 2025 and down from $116.0 million in Q2 2024
2025 cost of coal sales guidance lowered to $101 to $107 per ton from $103 to $110; SG&A guidance cut to $48 million to $54 million
Total liquidity of $556.9 million as of June 30, 2025; remaining buyback authorization of approximately $400 million
Wendy's reported second-quarter 2025 results for the quarter ended June 29, 2025. Revenue and global systemwide sales declined, while diluted earnings per share rose 7.4% to $0.29, helped by a lower share count. The company lowered its full-year 2025 adjusted EPS and adjusted EBITDA outlook, which matters to shareholders because it signals weaker expected profit for the year.
Total revenues were $560.9 million, down 1.7% from $570.7 million a year earlier; diluted EPS was $0.29, up 7.4% from $0.27.
Global systemwide sales were $3.7 billion, down 1.8%; U.S. same-restaurant sales fell 3.6%, while International systemwide sales grew 8.7%.
Full-year adjusted EPS outlook is now $0.82 to $0.89, down from $0.92 to $0.98; adjusted EBITDA outlook is now $505 million to $525 million, down from $530 million to $545 million.
The board declared a regular quarterly dividend of $0.14 per share, payable September 16, 2025, to holders of record as of September 2, 2025.
Victory Capital reported second-quarter 2025 revenue of $351.2 million, up 59.9% from a year earlier, after closing its Amundi US acquisition on April 1, 2025. GAAP net income fell 21% to $58.7 million and GAAP diluted EPS was $0.68 versus $1.12, as higher variable operating expenses and acquisition and restructuring costs pushed the GAAP operating margin down to 26.8%. The board raised the share repurchase authorization to $500 million and approved a $0.49 quarterly dividend.
Revenue was $351.2 million, up 59.9% from a year earlier and from $219.6 million in the first quarter of 2025.
GAAP diluted EPS was $0.68 versus $1.12 a year earlier; adjusted net income with tax benefit per diluted share was $1.57 versus $1.31.
GAAP operating margin was 26.8% versus 50.4%; acquisition-related costs were $25.8 million and restructuring and integration costs were $14.0 million.
The share repurchase authorization rose from $200.0 million to up to $500.0 million; the $0.49 dividend is payable September 25, 2025.
Concentra Group Holdings Parent reported second-quarter 2025 revenue of $550.8 million, up 15.2%, and raised its full-year 2025 revenue and Adjusted EBITDA guidance. Net income fell 12.9% to $46.2 million, and earnings per share fell to $0.35 from $0.50, which the company attributed to higher interest expense from its IPO recapitalization.
Q2 2025 revenue was $550.8 million, up 15.2% from $477.9 million; Adjusted EBITDA was $115.0 million, up 13.2% from $101.6 million.
Q2 2025 net income was $46.2 million versus $53.1 million a year earlier; EPS was $0.35 versus $0.50.
2025 revenue guidance was raised to $2.13 billion to $2.16 billion, and Adjusted EBITDA guidance is $420 million to $430 million.
The board declared a cash dividend of $0.0625 per share, payable August 28, 2025, to holders of record on August 21, 2025.
Synaptics reported fourth-quarter fiscal 2025 revenue of $282.8 million, up from $247.4 million a year earlier, but a GAAP net loss of $4.7 million, compared with net income of $208.3 million a year earlier. The company also guided first-quarter fiscal 2026 revenue to $290 million plus or minus $10 million and authorized a new buyback of up to $150 million of common stock, which has no expiration date.
Q4 non-GAAP diluted EPS was $1.01, versus $0.64 a year earlier; Q4 GAAP loss was $0.12 per basic share.
Prior-year Q4 GAAP net income of $208.3 million included a $245.0 million income tax benefit.
Q1 fiscal 2026 guidance: revenue $290 million ± $10 million; GAAP loss per share ($0.54) ± $0.25.
Board authorized the buyback of up to $150 million on August 5, 2025; the company repurchased $128 million of stock in fiscal 2025.
Onto Innovation reported fiscal second quarter 2025 revenue of $253.6 million, up 5% from a year earlier, while GAAP net income fell to $33.9 million, or $0.69 per share, from $52.9 million, or $1.07 per share. The company guided third-quarter revenue to $210 million to $225 million and announced a pending acquisition of Semilab product lines for approximately $545 million in cash and stock.
Q2 2025 revenue of $253.6 million, up 5% year-over-year; GAAP operating margin 12.7% vs. 20.2% a year earlier
Non-GAAP net income of $61.3 million, or $1.25 per share, vs. $65.4 million, or $1.32 per share, in Q2 2024
Q3 2025 outlook: revenue of $210 million to $225 million and GAAP diluted EPS of $0.52 to $0.72
Semilab acquisition for approximately $545 million in cash and stock, expected to add more than $130 million in annual revenue
Kratos reported second quarter 2025 revenue of $351.5 million, up 17.1 percent from $300.1 million a year earlier, while GAAP net income fell to $2.9 million, or $0.02 per share, from $7.9 million, or $0.05. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance and gave initial third-quarter guidance, but the second-quarter bookings-to-revenue ratio was 0.7 to 1.
Q2 2025 revenue was $351.5 million, up from $300.1 million, with organic growth of 15.2 percent.
GAAP net income was $2.9 million, or $0.02 per share, versus $7.9 million, or $0.05 per share, in Q2 2024; Adjusted EPS was $0.11 versus $0.14.
Full-year 2025 revenue guidance is $1.29 billion to $1.31 billion and Adjusted EBITDA guidance is $114 million to $120 million, both increased.
KUS segment reported an operating loss of $0.3 million in Q2 2025, compared with operating income of $3.6 million a year earlier.
DiamondRock reported second-quarter 2025 net income attributable to common stockholders of $38.4 million, or $0.18 per diluted share, up 73.8% from a year earlier, while total revenues fell 1.2% to $305.7 million and Adjusted EBITDA fell 4.7% to $90.5 million. The company raised the midpoint of its 2025 Adjusted EBITDA and Adjusted FFO per share guidance and completed a $1.5 billion credit facility refinancing that it says leaves no debt maturities until 2028.
Net income attributable to common stockholders was $38.4 million, or $0.18 per diluted share, versus $22.1 million in the second quarter of 2024.
Total revenues were $305.7 million, down 1.2% from $309.3 million; Adjusted EBITDA was $90.5 million, down 4.7%.
2025 Adjusted EBITDA guidance is $275 million to $295 million, with the midpoint raised by $2.5 million; Adjusted FFO per share guidance is $0.96 to $1.06, with the midpoint raised by $0.01.
On July 22, 2025, the company completed a $1.5 billion refinancing of its senior unsecured credit facility.
BioLife Solutions reported unaudited second-quarter 2025 revenue of $25.4 million, up 29% from a year earlier, and raised its full-year 2025 revenue guidance to $100.0 million to $103.0 million. The GAAP net loss widened to $15.8 million, which includes a non-cash $15.5 million in-process R&D expense tied to the April 2025 PanTHERA acquisition.
Q2 2025 total revenue was $25.4 million, up from $19.7 million in Q2 2024.
GAAP net loss from continuing operations was $15.8 million, versus $5.6 million a year earlier, including a $15.5 million non-cash IPR&D expense.
Full-year 2025 revenue guidance was raised to $100.0 million to $103.0 million from $95.5 million to $99.0 million.
Adjusted EBITDA was $6.1 million, or 24% of revenue, compared with $3.9 million, or 20% of revenue, in Q2 2024.
Arrowhead Pharmaceuticals reported results for the fiscal 2025 third quarter ended June 30, 2025, with revenue of $27.8 million compared with none a year earlier. The net loss attributable to the company was $175.2 million, up from $170.8 million, while the diluted loss per share narrowed to $1.26 from $1.38. The filing also described a $130 million upfront payment from Sanofi tied to a Greater China deal for a majority-owned subsidiary, and a $100 million Sarepta milestone payment.
Revenue of $27.8 million in the quarter, versus $0 in the same period a year earlier
Net loss attributable to Arrowhead of $175.2 million, versus $170.8 million a year earlier; diluted loss per share of $1.26, versus $1.38
Research and development expenses of $162.4 million and general and administrative expenses of $30.9 million
Total cash resources of $900.4 million as of June 30, 2025, and a PDUFA action date of November 18, 2025 for plozasiran
LegalZoom reported second-quarter 2025 revenue of $192.5 million, up 9% year over year, and a net loss of $0.3 million, compared with net income of $1.3 million a year earlier. The company raised its full-year 2025 revenue growth outlook to approximately 8% from 5%, while keeping its Adjusted EBITDA margin outlook at approximately 23%, so shareholders get faster top-line growth alongside a swing to a small loss.
Q2 revenue $192.5 million, up 9% year over year; subscription revenue $119.9 million, up 10%
Q2 net loss $0.3 million versus net income $1.3 million in Q2 2024; Adjusted EBITDA $39.0 million versus $28.9 million
2025 revenue growth outlook raised to approximately 8% from 5%; Adjusted EBITDA margin outlook maintained at approximately 23%
Q3 2025 outlook: revenue of $182 million to $184 million and Adjusted EBITDA of $44 million to $46 million
Expedia Group reported second quarter 2025 revenue of $3,786 million, up 6% from a year earlier, and gross bookings of $30,409 million, up 5%. GAAP diluted earnings per share fell 11% to $2.48, while adjusted EPS rose 21% to $4.24, and the company raised its full-year 2025 guidance. The company also declared a quarterly dividend of $0.40 per share and repurchased $627 million of shares in the quarter.
Q2 2025 revenue $3,786 million, up 6%; gross bookings $30,409 million, up 5%
GAAP diluted EPS $2.48, down 11%; adjusted EPS $4.24, up 21%
Full-year 2025 gross bookings guidance raised to 3-5% from 2-4%; revenue guidance raised to 3-5% from 2-4%
Quarterly dividend of $0.40 per share payable September 18, 2025 to holders of record on August 28, 2025
APA reported second-quarter 2025 net income attributable to common stock of $603 million, or $1.67 per diluted share, up from $541 million, or $1.46, a year earlier, while total revenues fell to $2.18 billion from $2.54 billion. The company also accelerated its cost-reduction program to $350 million in run-rate savings by 2026 and reduced net debt by more than $850 million during the quarter, which matters to shareholders because it bears on both earnings quality and balance-sheet strength.
Net income attributable to common stock was $603 million, or $1.67 per diluted share, versus $541 million, or $1.46, in Q2 2024.
Total revenues were $2.18 billion, compared with $2.54 billion in the same quarter last year; adjusted earnings were $313 million, or $0.87 per diluted share.
Net debt fell to $4.4 billion at June 30, 2025, from $5.3 billion at March 31, 2025; APA returned $140 million to shareholders through dividends and buybacks.
The 2026 run-rate savings target of $350 million was pulled forward from year-end 2027, and the 2025 realized savings target rose to $200 million from $130 million.
Sabre reported second-quarter 2025 revenue of $687 million, down 1% from $695 million a year earlier, and a net loss attributable to common stockholders of $256 million, versus $70 million in the second quarter of 2024. Operating income rose to $89 million from $49 million, but the larger loss reflected higher tax provisions and an $85 million loss on debt extinguishment, and the company also updated its full-year 2025 outlook.
Revenue was $687 million, down 1% from $695 million in Q2 2024; net loss attributable to common stockholders was $256 million, versus $70 million.
Operating income was $89 million, up from $49 million, with operating margin of 13% versus 7%.
Closed the $1.1 billion sale of Hospitality Solutions in July 2025 and repaid more than $1 billion of debt.
Full-year 2025 pro forma Adjusted EBITDA scenarios range from about $530 million to $570 million, depending on industry bookings growth.
Collegium reported second-quarter 2025 product revenue of $188.0 million, up 29% from a year earlier, and raised its full-year 2025 product revenue guidance to $745 million to $760 million. GAAP net income fell to $12.0 million, or $0.34 per diluted share, from $19.6 million, or $0.52, a year earlier, as operating expenses rose. The company also authorized a $150 million share repurchase program running through December 31, 2026.
Q2 2025 product revenue of $188.0 million, up 29% year over year; Jornay PM net revenue of $32.6 million, with prescriptions up 23%
Full-year 2025 product revenue guidance raised to $745 million to $760 million, from $735 million to $750 million; adjusted EBITDA guidance raised to $440 million to $455 million
GAAP net income of $12.0 million ($0.34 diluted EPS) for Q2 2025, versus $19.6 million ($0.52) for Q2 2024
Board authorized a $150 million share repurchase program through December 31, 2026; cash and marketable securities were $222.2 million at June 30, 2025
Cogent Communications reported second-quarter 2025 service revenue of $246.2 million, down 0.3% from the first quarter and 5.5% from a year earlier, and a net loss of $57.8 million, or $(1.21) per share, compared with $(1.09) per share in the first quarter. The company also raised its quarterly dividend to $1.015 per share and increased its buyback program by $100.0 million, which matters to shareholders because it changes capital returns while headline revenue and loss figures moved in opposite directions.
Service revenue was $246.2 million for Q2 2025, versus $247.0 million for Q1 2025 and a 5.5% decline from Q2 2024.
Net loss was $57.8 million, or $(1.21) per share, versus $(1.09) per share in Q1 2025; EBITDA rose 10.8% sequentially to $48.5 million.
Net cash used in operating activities was $44.0 million in Q2 2025, compared with $36.4 million provided in Q1 2025.
The Board approved a regular quarterly dividend of $1.015 per share payable September 5, 2025, and a $100.0 million buyback increase running through December 31, 2026; $7.9 million remained available as of July 31, 2025.
Dentsply Sirona reported second-quarter 2025 net sales of $936 million, down 4.9% from a year earlier, and a GAAP net loss of $45 million, or $0.22 per share, driven by a $214 million net-of-tax goodwill and intangible impairment. Adjusted EPS rose to $0.52 from $0.49, and the company reaffirmed its 2025 outlook, though sales and the impairment charge weigh on the picture for shareholders.
Net sales of $936 million fell 4.9% from $984 million; down 6.7% in constant currency, with United States sales down 18.3%.
GAAP net loss attributable to Dentsply Sirona of $45 million, or $0.22 per share, versus a $4 million loss ($0.02 per share) in the second quarter of 2024.
Adjusted EPS of $0.52 compared with $0.49; 2025 outlook maintained at net sales of $3.60 billion to $3.70 billion and adjusted EPS of $1.80 to $2.00.
Dan Scavilla became CEO effective August 1, 2025; quarterly dividend of $0.16 per share is payable October 10, 2025.
N-able reported second-quarter 2025 revenue of $131.2 million, up 9.9% year over year, and total ARR of $513.7 million, up 14.5%. The company said it exceeded the high end of its second-quarter revenue and adjusted EBITDA guidance and raised its full-year 2025 ARR outlook to $525 million to $530 million, but GAAP net loss was $4.0 million, compared with net income of $9.5 million a year earlier.
Q2 2025 total revenue was $131.2 million, up 9.9% year over year (7.9% in constant currency).
GAAP net loss was $4.0 million, or $0.02 per diluted share, versus net income of $9.5 million in Q2 2024; non-GAAP net income was $20.4 million, or $0.11 per diluted share.
Full-year 2025 ARR outlook was raised to $525 million to $530 million; full-year revenue outlook is $500 million to $503 million.
Q3 2025 guidance calls for revenue of $127 million to $128 million and adjusted EBITDA of $36 million to $37 million.
Insulet reported second-quarter 2025 revenue of $649.1 million, up 32.9% from a year earlier, and raised its full-year 2025 total revenue growth guidance to 24% to 27% in constant currency, from 19% to 22%. GAAP net income fell to $22.5 million, or $0.32 per diluted share, from $188.6 million, or $2.59, a year earlier; that prior-year figure included a tax benefit, and this year's quarter included an $84.4 million loss on extinguishment of debt. Shareholders face a mixed picture: sales and adjusted earnings rose, while GAAP profit declined sharply.
Total Omnipod revenue was $639.0 million, up 33.0%; U.S. Omnipod revenue was $453.2 million, up 28.7%, and International Omnipod revenue was $185.8 million, up 45.0%.
Full-year 2025 adjusted operating margin guidance was raised to 17.0% to 17.5% from about 16.5%.
Adjusted net income was $83.7 million, or $1.17 per diluted share, compared with $38.3 million, or $0.55, a year earlier.
The company initiated redemption of the remaining $380 million principal of its convertible notes and refinanced its Term Loan B.
Crocs reported second-quarter 2025 revenue of $1,149 million, up 3.4%, but a GAAP net loss of $492 million, or $8.82 per diluted share, driven by $737 million in noncash impairment charges tied to the HEYDUDE brand. The company guided third-quarter revenue down approximately 9% to 11%, which signals a sales decline ahead for shareholders.
Q2 2025 revenue was $1,149 million, up 3.4%; adjusted diluted EPS was $4.23, up 5.5% from $4.01.
GAAP diluted loss per share was $8.82, versus diluted earnings of $3.77 a year earlier, due to a $430 million HEYDUDE trademark impairment and a $307 million HEYDUDE goodwill impairment.
Third-quarter 2025 guidance calls for revenue down approximately 9% to 11% versus Q3 2024, and adjusted operating margin of approximately 18% to 19%.
The company repurchased about 1.3 million shares for $133 million and repaid $105 million of debt in the quarter.
Vistra reported second-quarter 2025 operating revenues of $4,250 million, up from $3,845 million a year earlier, but GAAP net income fell to $327 million from $467 million and Ongoing Operations Adjusted EBITDA fell to $1,349 million from $1,412 million, which the company attributed mainly to higher plant outage costs. Vistra reaffirmed its 2025 Ongoing Operations Adjusted EBITDA guidance of $5.5 billion to $6.1 billion and raised its 2026 Adjusted EBITDA midpoint opportunity to more than $6.8 billion, excluding a planned acquisition of seven natural gas facilities of about 2,600 MW from Lotus Infrastructure Partners.
Q2 2025 GAAP net income was $327 million, down $140 million from $467 million in Q2 2024.
Ongoing Operations Adjusted EBITDA was $1,349 million, down $63 million from $1,412 million a year earlier.
2025 Ongoing Operations Adjusted EBITDA guidance of $5.5 billion to $6.1 billion was reaffirmed.
Vistra signed a definitive agreement to acquire seven natural gas facilities of about 2,600 MW from Lotus Infrastructure Partners.
Peloton reported fiscal fourth-quarter and full-year FY2025 results on August 7, 2025. Q4 total revenue fell 6% year-over-year to $606.9 million, while GAAP net income was $21.6 million, compared with a net loss of $30.5 million a year earlier, and Adjusted EBITDA rose 99% to $140.0 million. The company guided FY26 total revenue to $2.4 billion to $2.5 billion, a 2% decline at the midpoint, and announced a restructuring plan targeting at least $100 million of run-rate savings by the end of FY26.
Q4 FY25 total revenue was $606.9 million, down 6% year-over-year, with Total Gross Margin of 54.1%.
Q4 GAAP net income was $21.6 million versus a net loss of $30.5 million in Q4 FY24; Adjusted EBITDA was $140.0 million.
FY26 guidance: total revenue of $2.4 billion to $2.5 billion and Adjusted EBITDA of $400 million to $450 million.
Q1 FY26 total revenue is guided to $525.0 million to $545.0 million, down 9% at the midpoint; restructuring targets at least $100 million of run-rate savings by the end of FY26.
Hyatt reported second-quarter 2025 net loss attributable to the company of $3 million, or $(0.03) per diluted share, compared with net income of $359 million a year earlier, which included gains on sales of real estate. Revenue rose to $1,808 million from $1,703 million and gross fees rose 9.5%, while adjusted EBITDA fell 1.1% to $303 million. The company also set full-year 2025 net income guidance of $135 million to $165 million, down sharply from $1,296 million in 2024, and disclosed the pending $2.0 billion sale of Playa's real estate.
Q2 2025 net loss attributable to Hyatt of $3 million, or $(0.03) per diluted share, versus net income of $359 million, or $3.46 per diluted share, in Q2 2024
Q2 revenue of $1,808 million, up from $1,703 million; gross fees of $301 million, up 9.5%; adjusted EBITDA of $303 million, down 1.1%
Transaction and integration costs of $82 million in Q2 2025 versus $10 million a year earlier
Full-year 2025 net income outlook of $135 million to $165 million versus $1,296 million in 2024; Playa real estate sale to Tortuga Resorts for $2.0 billion expected to close before end of 2025
Somnigroup reported second-quarter 2025 net sales of $1.88 billion, up 52.5%, mainly due to the inclusion of Mattress Firm sales. Diluted EPS fell 21.7% to $0.47 and net income fell 6.7% to $99.0 million, while adjusted EPS fell 15.9% to $0.53. The company raised its full-year 2025 adjusted EPS outlook to $2.40 to $2.70 and declared a $0.15 quarterly dividend.
Net sales rose 52.5% to $1,880.8 million, with $948.8 million from Mattress Firm.
Diluted EPS was $0.47 versus $0.60 a year earlier; adjusted EPS was $0.53 versus $0.63.
Full-year 2025 adjusted EPS guidance raised to a range of $2.40 to $2.70.
Quarterly cash dividend of $0.15 per share payable September 5, 2025, to holders of record on August 21, 2025.
Zimmer Biomet reported second-quarter 2025 net sales of $2.077 billion, up 7.0% from a year earlier, and adjusted diluted EPS of $2.07, up 3.0%. GAAP diluted EPS fell to $0.77 from $1.18 as net earnings dropped to $152.8 million from $242.8 million, and the company cited higher acquisition-related and other costs. The company raised its full-year 2025 adjusted EPS guidance to $8.10-$8.30 from $7.90-$8.10 and tightened its reported revenue growth guidance to 6.7%-7.7%.
Q2 2025 net sales were $2.077 billion, up 7.0% on a reported basis and 2.8% on an organic constant currency basis.
GAAP diluted EPS was $0.77 versus $1.18 a year earlier; acquisition, integration and related charges were $78.9 million in the quarter.
Full-year 2025 adjusted diluted EPS guidance rose to $8.10-$8.30 from $7.90-$8.10.
Full-year 2025 reported revenue growth guidance was tightened to 6.7%-7.7% from 5.7%-8.2%.
Enovis reported second-quarter 2025 net sales of $565 million, up 7% on a reported basis, and raised its full-year 2025 revenue, adjusted EBITDA and adjusted EPS guidance. The company still posted a larger GAAP net loss of $37 million, or $0.64 per share, compared with a loss of $18.5 million, or $0.34 per share, a year earlier.
Q2 2025 net sales of $565 million, up 7% reported and 5% organic, versus the prior-year quarter
Q2 net loss of $37 million ($0.64 per share) versus a net loss of $18.5 million ($0.34 per share) in Q2 2024; adjusted EPS was $0.79 versus $0.62
Full-year 2025 revenue guidance raised to $2.245-2.275 billion from $2.220-2.250 billion; adjusted EPS guidance raised to $3.05-3.20 from $2.95-3.10
Q2 included a $10.0 million charge for the purchase of a royalty interest; adjusted EBITDA was $97 million, or 17.2% of sales
Privia Health reported second-quarter 2025 total revenue of $521.2 million, up 23.4% from a year earlier, and raised its full-year 2025 guidance. GAAP net income attributable to Privia shareholders fell to $2.7 million from $3.5 million, while non-GAAP adjusted net income per diluted share rose to $0.24 from $0.19. The results are preliminary and unaudited until the company's Form 10-Q is filed.
Q2 2025 total revenue was $521.2 million, versus $422.3 million in Q2 2024, up 23.4%.
Q2 net income attributable to Privia shareholders was $2.7 million, or $0.02 per diluted share, versus $3.5 million, or $0.03, a year earlier.
Q2 Adjusted EBITDA was $29.0 million, up 31.6% from $22.0 million.
Updated FY 2025 guidance includes GAAP revenue of $1.8 billion to $1.9 billion and Adjusted EBITDA of $105 million to $110 million, both above the high end of the prior range.
Talen Energy reported second quarter 2025 GAAP net income attributable to stockholders of $72 million, down from $454 million a year earlier, mainly because a 2024 gain on the ERCOT portfolio sale did not recur. Adjusted EBITDA rose slightly to $90 million, but Adjusted Free Cash Flow was a use of $(78) million, and the company reaffirmed its 2025 guidance while agreeing to buy two gas plants for a net price of $3.5 billion.
Q2 2025 GAAP net income attributable to stockholders was $72 million, compared with $454 million in Q2 2024.
Q2 2025 Adjusted EBITDA was $90 million, up $3 million from $87 million, while Adjusted Free Cash Flow was $(78) million, compared with $(29) million.
2025 guidance reaffirmed: Adjusted EBITDA of $975 million to $1.125 billion and Adjusted Free Cash Flow of $450 million to $540 million.
Agreements to acquire the Freedom and Guernsey plants have a net price of $3.5 billion and are expected to close in the fourth quarter of 2025.
EPAM reported second-quarter 2025 revenue of $1.353 billion, up 18.0% year over year, and raised its full-year 2025 revenue growth outlook to 13.0% to 15.0%. GAAP diluted earnings per share fell 8.2% to $1.56, while non-GAAP diluted EPS rose 13.1% to $2.77, so shareholders see higher sales and a raised revenue outlook alongside lower GAAP profit per share.
Q2 2025 revenue was $1.353 billion, up 18.0%; organic constant currency revenue rose 5.3%.
GAAP diluted EPS was $1.56, down from $1.70 (down 8.2%); non-GAAP diluted EPS was $2.77, up 13.1% from $2.45.
Full-year 2025 revenue growth outlook raised to 13.0% to 15.0%; organic constant currency growth outlook is 3.0% to 5.0%.
Third-quarter 2025 revenue is expected in the range of $1.365 billion to $1.380 billion.
Talos Energy reported second-quarter 2025 results on August 6, 2025, with a net loss of $185.9 million that included a $223.9 million non-cash impairment charge. The company also improved its full-year 2025 guidance, citing higher production, lower operating expenses and lower capital expenditures, and reported $357.3 million of cash at June 30, 2025.
Net loss of $185.9 million, or $1.05 per diluted share, including a $223.9 million non-cash ceiling test impairment; adjusted net loss of $48.3 million, or $0.27 per share
Total revenues of $424.7 million, Adjusted EBITDA of $294.2 million and net cash from operating activities of $351.6 million for the quarter
Full-year 2025 production guidance revised to 91.0 to 95.0 MBoe/d from 90.0 to 95.0 MBoe/d; cash operating expenses and workovers guidance lowered to $555 million to $585 million
Repurchased 3.8 million shares for $32.6 million in the quarter; net debt of $892.7 million and net debt to LTM Adjusted EBITDA of 0.7x at June 30, 2025
Chord Energy reported a second-quarter 2025 net loss of $389.9 million, or $6.77 per diluted share, after a $539.3 million non-cash goodwill impairment that reduced goodwill to zero. Adjusted net income was $103.2 million ($1.79 per diluted share), down from $234.9 million in the second quarter of 2024, while the company raised its full-year 2025 oil production guidance and lowered its capital spending guidance, and declared a $1.30 per share base dividend.
Q2 2025 net loss of $389.9 million ($6.77 per diluted share); Adjusted EBITDA of $547.2 million versus $567.9 million in Q2 2024
Non-cash goodwill impairment charge of $539.3 million, reducing goodwill to zero as of June 30, 2025
FY25 oil production guidance raised 500 barrels per day at midpoint to 153.0 MBopd; E&P and other CapEx lowered $20 million to $1.35 billion at midpoint
Base dividend of $1.30 per share payable September 8, 2025; new $1 billion share repurchase program authorized
Helmerich & Payne reported a fiscal third-quarter net loss of $163 million, or $1.64 per share, compared with net income of $0.01 per share in the prior quarter, after a $173 million non-cash goodwill impairment. Excluding this and other one-time items, earnings were $22 million, or $0.22 per share, and revenue rose to $1.04 billion from $1.02 billion in the prior quarter. The company also raised its fiscal 2025 gross capital expenditure estimate to $380-$395 million.
Q3 fiscal 2025 net loss of $163 million, or $1.64 per diluted share, versus $0.88 per diluted share in the year-earlier quarter
Operating revenues of $1.04 billion, up from $1.02 billion in the prior quarter
Q4 fiscal 2025 North America Solutions direct margin guidance of $230-$250 million
Term loan repayment expected to total $200 million by end of calendar 2025, up from the prior $175 million expectation
Global Net Lease reported second-quarter 2025 revenue of $124.9 million, down from $145.5 million a year earlier, mainly due to asset dispositions including the multi-tenant retail portfolio sale. The company narrowed its net loss attributable to common stockholders to $35.1 million from $46.6 million and raised the low end of its 2025 AFFO per share guidance to a range of $0.92 to $0.96.
Revenue was $124.9 million versus $145.5 million in second quarter 2024, primarily reflecting asset dispositions.
Net loss attributable to common stockholders was $35.1 million, or $0.16 per diluted share, versus $46.6 million, or $0.20 per share, a year earlier.
AFFO was $53.1 million, or $0.24 per share, versus $76.7 million, or $0.33 per share, in second quarter 2024.
The low end of 2025 AFFO per share guidance was raised to a new range of $0.92 to $0.96; the Net Debt to Adjusted EBITDA range of 6.5x to 7.1x was reaffirmed.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.